Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Conventional transarterial chemoembolization (cTACE)
OTHER
2 trials
Sponsors
National Cancer Center, Korea
, Second Affiliated Hospital of Guangzhou Medical University
Conditions
Advanced Adult Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Phase 3
A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC
Completed
NCT01829035
National Cancer Center, Korea
Advanced Adult Hepatocellular Carcinoma
Start: 2013-02-21
End: 2017-06-21
Updated: 2018-03-29
Unknown Phase
DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC
NCT04967482
Second Affiliated Hospital of Guangzhou Medical University
Hepatocellular Carcinoma Non-resectable
Start: 2021-07-09
End: 2024-07-08
Target: 216
Updated: 2022-09-15
Related Papers
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
Journal of Hepatology
2018-12-06
194 citations